Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells In vitro
- 30 November 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (12), 1909-1914
- https://doi.org/10.1016/0277-5379(87)90058-7
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- In vitro activity of menogaril and N-demethylmenogaril in a human tumor cloning assayEuropean Journal of Cancer and Clinical Oncology, 1986
- Idarubicin (4-demethoxydaunorubicin)Investigational New Drugs, 1986
- Phase I clinical evaluation of oral and intravenous 4-demethoxydaunorubicinEuropean Journal of Cancer and Clinical Oncology, 1985
- Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1985
- 4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot studyCancer, 1985
- Plasma concentrations of carminomycin and carminomycinol in man, measured by high pressure liquid chromatographyEuropean Journal of Cancer and Clinical Oncology, 1982
- Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapyAmerican Journal Of Medicine, 1981
- Primary Bioassay of Human Tumor Stem CellsScience, 1977
- The pharmacokinetics of daunomycin in manClinical Pharmacology & Therapeutics, 1971
- Human bone marrow colony growth in agar‐gelJournal of Cellular Physiology, 1970